2 min read
New CAP eCP Reporting Tool. There's a new solution on the market designed to streamline CAP cancer reporting with unmatched accuracy and compliance.
SynoptIQ simplifies and improves the cancer reporting process. It's the newest addition to Voicebrook's suite of pathology reporting tools.
With SynoptIQ, labs enjoy the ease of compliance with seamless CAP updates, reduction of user errors with decision support, and the clarity of structured reports. SynoptIQ addresses the needs of labs that want a full-featured eCP solution, solely focused on CAP cancer reporting, at a budget-friendly price point.
Compatible with any AP/LIS system, SynoptIQ features structured data capture, customized content, automatic staging and grading, automatic updates with every new CAP release, and direct access to CAP protocols. Interoperability is a breeze with HL7 data output.
“Our customers have been extremely satisfied with the benefits of our CAP eCP tool,” says E. Bruce Sopko, Vice President of Sales at Voicebrook. “SynoptIQ’s blend of convenience and technology makes it the ideal solution for enhancing both accuracy and efficiency in the cancer reporting process, ultimately improving patient care.”
2024 Pathologists Leadership Summit. The College of American Pathologists' 2024 Pathologists Leadership Summit is an in-person event, scheduled for April 13-16 in Washington, D.C. It not only offers education and training for personal and professional growth, but provides unparalleled access to put those tools into action on Capitol Hill. Pathologists meet directly with legislators and their staff on Hill Day to advocate for pathology and its critical impact on patient care.
The CAP has designated the Pathologists Leadership Summit as an educational activity for a maximum of 13.50 American Medical Association (AMA) PRA Category 1 Credits. AMA PRA Category 1 Credit is used for meeting CME requirements established by hospital credentialing bodies, state medical boards, medical specialty certifying boards, medical specialty societies, Joint Commission, and other organizations.
Register online.
FDA Clearance for Proscia's New Digital Pathology Tool. Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Concentriq® AP-Dx. The digital pathology solution was cleared for the purpose of primary diagnosis, for clinical use with the Hamamatsu NanoZoomer S360MD Slide scanner in the U.S.
Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images and helps to drive confidence and efficiency gains. It can also streamline collaboration, broadening access to expertise. Concentriq AP-Dx was designed to be used in clinical settings of all sizes, from individual reference laboratories to the largest hospital systems.
“This regulatory milestone reflects our tireless commitment to our mission of perfecting cancer diagnosis,” said David West, Proscia’s CEO. “Pathologists are facing more pressure than ever before in the fight against some of humanity’s biggest challenges. With 510(k) clearance, we can help more laboratories improve the pathologist experience and better serve their patients.”
Founded in 2002, Voicebrook is the leading provider of reporting solutions for pathology, with more than 550 client sites across the US, Canada, and Australia.
Leverage the power of customized templates and the efficiency of speech recognition with VoiceOver PRO, a revolutionary reporting solution that's tailored to the unique needs of anatomic pathology.
SynoptIQ is a full-featured eCP solution solely focused on CAP cancer reporting, at a budget-friendly price point. SynoptIQ is where specificity and efficiency meet.
